Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline glycaemic status and body mass index: a DAPA-MI substudy

Authors: R F Storey, J Deanfield, S James, R Ajjan, N Eriksson, D Erlinge, M De Belder, C P Gale, A Zaman, R Hofmann, Y Jiang, A M Langkilde, E Parvaresh Rizi, J Oldgren, D K Mcguire

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.1418

Source: Full article

Impact of dapagliflozin on cardiometabolic outcomes after myocardial infarction according to baseline glycaemic status and body mass index: a DAPA-MI substudy

Abstract